.,14.5.08 -- PPreressentation in several entation in several national meetingsnational meetings
History of ČARO- GARD.CZ
Medical societies (parts of MS J.E.Purkyně) Czech Pneumological and Phthisiological Society
Czech Society of Allergology and Clinical Immunology Czech Oncological Society
Czech Sleep Research Society Society of Occupational Medicine Society of Occupational Diseases
Working Group of Paediatric Pneumology Association of General Practitioners
Society of General Medicine Professional Society of Paediatric Practitioners Society for Treatment of Tobacco Addiction
Pneumological Section of Czech National Nurses Association
WHO Czech Country Office
Společnosti a sdružení podporující ČARO Collaborating parties of
ČARO
Nongovernmental Organisations Nongovernmental Organisations
Czech Civic Association against COPD (Czech Civic Association against COPD (ČČOPN)OPN) Czech Czech Initiative Initiative for Asthma (for Asthma (ČČIPA)IPA) National CentNational Centrre for Severe Asthma e for Severe Asthma
CCzechzech Cystic FibrosisCystic Fibrosis AssociationAssociation Association of Allergic and Asthmatic Children, Brno Association of Allergic and Asthmatic Children, Brno Association for Helping Chronically Ill Children, PraAssociation for Helping Chronically Ill Children, Praguegue
SPCCH ZO Club of Asthmatics, Olomouc SPCCH ZO Club of Asthmatics, Olomouc SPCCH ZO Association of Respiratory Ill Patients, SPCCH ZO Association of Respiratory Ill Patients,
Hradec KrHradec Kráálovlovéé
Collaborative parties of ČARO
Non-infective, mostly lifetime, incurable diseases
High social and economical burden
High morbidity and invalidity (DALY)
Increasing mortality, predominantly in women
Underdiagnosed and undertreated diseases
Some of them related to professional environment
Some begin in childhood, other in old age
Strongly related to smoking
Chronic respiratory diseases- comprehensive characteristics
COPD chronic pleuritis
asthma bronchiale hypersensitive pneumonitis
lung cancer pleural mesothelioma
bronchiectases sarcoidosis
lung fibrosis chronic sinusitis
chronic rhinopathies pulmonary hypertension
cystic fibrosis pulmonary eosinofilia
pneumoconioses mediastinal tumours
sleep apnoe syndrome bronchopulmonal dysplasia
Chronic respiratory diseases National Programme constituted by ČARO
Mortality – 8 000 /year
0
500
1000
1500
2000
1997 1998 1999 2000 2001 2002 2003 2004 2005 year
COPD
Asthma
Mortality on COPD and asthma Mortality on COPD and asthma bronchiale in the Czech Republicbronchiale in the Czech Republic
0
2000
4000
6000
8000
10000
12000
19 95 19
97 19
99 20
01 20
02 20
03 20
04
Total no of people
Lineární (Total no of people)
1995 – 9 870
1997 – 8 934
1999 – 8 841
2001 – 8 195
2002 – 7 234
2003 – 7 029
2004 – 6 503
-- 34 %34 %
Number of hospitalizNumber of hospitalizationsations for asthma for asthma in the Czech Republicin the Czech Republic
Linear
0
1000
2000
3000
4000
5000
6000
1950 1960 1970 1980 1985 1990 1995 2000 2005
Men
Women
Lung cancer mortality in the CR
year
• Decrease of incidence, prevalence and mortality
• Quality of life improvement
• Rational utilization of diagnostic and therapeutic processes
National Programme for the Fight against CRD
Goals
• Prevention of CRD, antismoking activities
• Epidemiology and effective screening
• Management of highly specialized centres (smoking addiction, ICU, CF, severe asthma, SAS,pneumooncology)
National Programme for the Fight against CRD
Methods- coordination of:
freely breathing society
patients doctors
partners
political lobbying mass media
nurses
Promising future of GARD and ČARO Promising future of ČARO and GARD
Language:English
Score: 1466079.7
-
https://www.who.int/gard/news_...nts/9_kolek_czech_republic.pdf
Data Source: un
In their study, Jackson et al. look at the association between smoking and COVID-19 outcome measures, including confirmed positive tests and stress levels. (...) Wang et al found decreased levels of ACE2 among smokers [7]; Tomchaney et al [8] also reported decreased levels when exposing mice to cigarette smoke; and Caruso et al saw downregulation after exposing bronchial epithelial cells to cigarette smoke [9]. (...) Caruso, M.D., Alfio; et al., Role of Cigarette Smoke on ACE-2 Protein Membrane Expression in Bronchial Epithelial Cells Using an Air-Liquid Interface Model.
Language:English
Score: 1463878.3
-
https://www.who.int/fctc/cop/T...n's-COVID-19-Science-Brief.pdf
Data Source: un
Other risk factors are indoor pollution (biomass fuels used for cooking and heating), outdoor pollution and occupational dusts and chemicals (vapours, irritants and fumes).
Symptoms of COPD include cough, sputum production and breathlessness. (...) During an asthma attack, the lining of the bronchial tubes swell, causing the airways to narrow and reducing the flow of air into and out of the lungs.
(...) Although the fundamental causes of asthma are not completely understood, the strongest risk factors for developing asthma are inhaled asthma triggers. These include:
o indoor allergens (for example house dust mites in bedding, carpets and stuffed furniture, pollution and pet dander)
o outdoor allergens (such as pollens and moulds) o tobacco smoke o chemical irritants in the workplace
Other triggers can include cold air, extreme emotional arousal such as anger or fear, and physical exercise.
Language:English
Score: 1445609.5
-
https://www.who.int/respirator...%20sheet%20Launch%20Brazil.pdf
Data Source: un
Ozone and TSP samples above GL during 2004-2006 in urban areas. 0
5 10 15 20 25 30 35 40
2004 2005 2006
total TSP ozone
0 5
10 15 20 25 30 35 40
2004 2005 2006
total TSP ozone
Chisinau Workshop on Sustainable and Healthy
Transport 29-30 October 2008
Dinamic of general morbidity level on population in Chisinau, 2001-2005 (per 1000 population)
918,1 981,2
846,6
173,3 183,5
777 798,1 746,6 673,3 712,5
896 935,8
189,2183,1141,1
0
200
400
600
800
1000
1200
2001 2002 2003 2004 2005 years
m or
bi di
ty
G. population Adults Children
Chisinau Workshop on Sustainable and Healthy
Transport 29-30 October 2008
Fig. 4 General morbidity level and on respiratory diseases in children in Chişinău,during 2001-2005 (incidence per 1000)
777 798,1 746,6 673,3
712,5
214,1 257,8 246,5 217 224,6
0 100 200 300 400 500 600 700 800 900
2001 2002 2003 2004 2005 years
ge ne
ra l m
or bi
di ty
le ve
l
Total children Respiratory diseases
Chisinau Workshop on Sustainable and Healthy
Transport 29-30 October 2008
Fig.5 Morbidity on some respiratory diseases on children in Chişinău (chronic bronchitis; bronchial asthma)
2005-2006
31,1
33,6
31,2
33,8
2005
2006
asthma chronic bronchitis
Chisinau Workshop on Sustainable and Healthy
Transport 29-30 October 2008
Legal framework development • With WHO/Bonn Office support Moldova started in
September 2008 to develop a draft national Law (Guidelines on Ambient Air Quality).
• For this reason a Working Group was established under the leading role of the National Centre of Preventive Medicine. (...) Air quality monitoring and health impact evaluation in MDA
Importance of the problem
Main gaps
Air quality monitoring – Service for Preventive Medicine
Air quality monitoring – Service for Preventive Medicine
Dinamic of general morbidity level on population in Chisinau,2001-2005 (per 1000 population)
Fig. 4 General morbidity level and on respiratory diseases in children in Chişinău,during 2001-2005 (incidence per 1000)
Fig.5 Morbidity on some respiratory diseases on children in Chişinău (chronic bronchitis; bronchial asthma)2005-2006
Legal framework development
Legal framework development
Solutions and recommendations
Language:English
Score: 1366110.7
-
https://unece.org/fileadmin/DA...nau/Presentations/12Salaru.pdf
Data Source: un
Ozone (O ) is a major factor in asthma morbidity and mortality, while nitrogen 3 dioxide (NO )and sulfur dioxide (SO ) play a role in asthma, bronchial symptoms, lung inflammation 2 2 and reduced lung function.
Language:English
Score: 1300577.2
-
https://www.itu.int/en/publica...e/files/basic-html/page41.html
Data Source: un
UNICEF
"UNICEF continues supporting the healthcare systems of Ukraine, including through the delivery of vaccines against dangerous infections,” said UNICEF Ukraine Representative Murat Sahin. (...) It is worth to remind that the elderly and those with chronic diseases are most vulnerable and should be fully vaccinated, including with booster shots as appropriate. Vaccines are available at healthcare facilities and are free for administration”, - Guillaume Simonian, acting WHO Representative in Ukraine.
(...) The booster is especially recommended for people at higher risk from COVID-19, including elderly people, people with cancer, cardiovascular diseases, bronchial asthma and diabetes.
Language:English
Score: 1298281.8
-
https://www.unicef.org/ukraine...nes-to-ukraine-with-US-support
Data Source: un
They suffer from fever, diarrhea, bronchial and respiratory infections, as well as malnutrition.
Language:English
Score: 1276893.75
-
https://www.unv.org/node/2923/pdf
Data Source: un
One example is Garcinia kola which provides, inter alia : bactericidal twigs to be used as toothbrushes; nuts to cure bronchial infections; fruit flesh used as a purgative; bark for leather tanning; gum to cure gonorrhoea;
latex for cuts and wounds; and sap for skin diseases and parasites.
Language:English
Score: 1276893.75
-
https://www.fao.org/fileadmin/...er_Leakey/BOOK_REVIEW_TAA.docx
Data Source: un
The evidence referred to above could be
• clinical history and data from appropriate lung function tests related to exposure to the substance, confirmed by other supportive evidence which may include:
-- in vivo immunological test (e.g. skin prick test)
-- in vitro immunological test (e.g. serological analysis)
-- studies that may indicate other specific hypersensitivity reactions where immunological mechanisms of action have not been proven, e.g. repeated low- level irritation, pharmacologically mediated effects
-- a chemical structure related to substances known to cause respiratory hypersensitivity
• data from positive bronchial challenge tests with the substance conducted according to accepted guidelines for the determination of a specific hypersensitivity reaction.
8. (...) The results of positive bronchial challenge tests are considered to provide sufficient evidence for classification on their own. (...) However, if on the basis of the evidence, it can be demonstrated that these substances induce symptoms of asthma by irritation only in people with bronchial hyperreactivity, they should not be considered as respiratory sensitisers.
24.
Language:English
Score: 1238148.3
-
https://www.ilo.org/legacy/eng...fework/ghs/ghsfinal/ghsc08.pdf
Data Source: un
Through appropriate treatment such as using inhaled corticosteroids to ease bronchial inflammation, the number of asthma exacerbation and asthma-related deaths can be reduced.
(...) Volkov
©
Credits
Avoiding asthma triggers can reduce the severity of asthma
Asthma triggers can include cold air, extreme emotional arousal such as anger or fear, and physical exercise.
Language:English
Score: 1215114.4
-
https://www.who.int/news-room/...acts-in-pictures/detail/asthma
Data Source: un